Elekta (STO:EKTA B) said today it tapped Brainlab to distribute its stereotactic neurological devices across select markets in the European Union. The distribution agreement covers Elekta’s Leksell Vantage Steretactic target localization and coordinate referencing neurosurgery system, the company said, which received CE Mark approval in the EU in March. The device is currently pending 510(k) clearance […]
LivaNova (NSDQ:LIVN) said last week that it picked up former Johnson & Johnson medical device group chief financial officer Thad Huston as its new CFO, effective May 20. Huston will replace former CFO Vivid Sehgal, who coordinated with Huston during the transition. Huston spent more than 25 years with Johnson & Johnson, and held various positions, […]
German robotic surgical start-up Medineering said today it closed a Series A funding round led by its new strategic partner Brainlab. Through the partnership, Brainlab will aid Medineering as it works towards becoming a surgical robotic manufacturer, the companies said. Funds from the round support the commercialization of Medineering’s 1st robot, designed for endo and […]
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today announced an exclusive strategic alliance with Value Stream Partners, a company specializing in knee and hip replacement bundled payment program development and implementation. The announcement was made at the American Academy of Orthopaedic surgeons annual meeting this week. “This exclusive arrangement with VSP will further enable us to help […]
Jan Medical said today it obtained $7.5 million in Series C funding from partner Brainlab Inc, with funds slated to aid in completion of a clinical trial and filing for de novo clearance with the FDA and CE Mark approval in the European Union for its BrainPulse tool. Mountain View, Calif.-based Jan Medical’s BrainPulse device is designed to […]
The FDA today labeled a recall of Brainlab’s Cranial image-guided surgery system as a Class I recall over issues with potential inaccuracies in the navigation display. The federal watchdog labeled the recall as a Class I, the most serious type of recall issued by the FDA, which indicates “there is a reasonable probability that use of […]
Jan Medical is partnering with software-driven medtech firm Brainlab to gain FDA clearances via 2 clinical trials, the companies announced.
As part of the collaboration, Brainlab will add a representative to Jan Medical’s board, the companies said in a press release.
Mountain View, Calif.-based Jan Medical makes the the Nautilus NeuroWave, a portable, non-invasive brain sensing system designed to detect abnormal neurological conditions, including ischemic stroke, vasospasm, and concussion.